PHC-15-2014
PHC-15-2014
6 projects · €35,106,789 total EU contribution (project-level) · 66 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€35,106,789
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (13)
- France (9)
- Italy (7)
- Netherlands (7)
- SE (5)
- DK (4)
- Spain (4)
- BE (3)
- IE (3)
- UK (3)
- PL (2)
- AT (1)
- EE (1)
- FI (1)
- NO (1)
- PT (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Leiden University Medical Center2 projects · NL
- KU Leuven2 projects · BE
- REGIONH2 projects · DK
- UNIPD2 projects · IT
- ALACRIS1 projects · DE
- ARIES srl1 projects · IT
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- AOUP1 projects · IT
- BIOARCTIC AB1 projects · SE
- CUH1 projects · UK
- CARDIOLOGICUM HAMBURG GBR1 projects · DE
- CHU1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis ADIPOA2 · 643809 | H2020 | €5,999,000 | €246,250 | Details |
Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts SC0806 · 643853 | H2020 | €6,397,077 | €859,914 | Details |
Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) SCIENCE · 643478 | H2020 | €5,998,882 | €423,125 | Details |
Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes TREGeneration · 643776 | H2020 | €5,899,250 | €741,335 | Details |
Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap ARISE · 643597 | H2020 | €4,954,992 | €401,245 | Details |
Restoring tissue regeneration in patients with visceral Graft versus Host Disease. RETHRIM · 643580 | H2020 | €5,857,588 | €331,538 | Details |